| Detailed Quote for Acura Pharmaceuticals Inc. (ACUR) |
|
|
|
|
close
52 Week Information
52 Week High
 June 20, 2011
Close:
6.80
52 Week Low
 August 8, 2011
Close:
2.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
close
Exchange Information
Listed On
Nasdaq Small Caps (NSC)
Exchange |
|---|
NSC |
|
|
|
|
|
News and Media for Acura Pharmaceuticals Inc.
(ACUR)
|
|
|
News for ACUR
|
|
|
|
| 4:14 PM |
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire |
|
|
|
| 8:00 AM |
Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR - PR Newswire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals Announces Third Quarter 2011 Financial Results - Marketwire |
|
|
|
| 5:15 PM |
Acura Pharmaceuticals Provides an Update on Impede(TM) Technology - Marketwire |
|
|
|
| 12:04 PM |
Acura Pharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference - Marketwire |
|
|
|
| 6:33 AM |
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals, Inc. Names J. Bradley Rivet VP of Marketing - Marketwire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals Awarded Key U.S. Patent for Abuse Deterrent Drug Formulations - Marketwire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals to Present at the 2011 Stifel Nicolaus Healthcare Conference - Marketwire |
|
|
|
| 6:15 AM |
Robert Jones Appointed President & CEO and to the Board of Directors of Acura Pharmaceuticals, Inc. - Globe Newswire |
|
|
|
| 6:15 AM |
Acura Pharmaceuticals, Inc. Announces the Retirement of William A. Sumner From Board of Directors - Globe Newswire |
|
|
|
| 6:15 AM |
Acura Pharmaceuticals Receives $20 Million Milestone Payment - Globe Newswire |
|
|
|
| 6:00 AM |
Acura Pharmaceuticals, Inc. Announces Notice of Allowance for Third Aversion(R) Technology Patent - Globe Newswire |
|
|
|
| 6:00 AM |
Acura Pharmaceuticals, Inc. Announces Appointment of Robert Jones as Interim President and CEO - Globe Newswire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals, Inc. Announces the Passing of Andrew Reddick, President & CEO - Globe Newswire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals Reports First Quarter 2011 Financial Results and Product Development Update - Globe Newswire |
|
|
|
| 4:10 PM |
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave - Globe Newswire |
|
|
|
| 4:15 PM |
Acura Pharmaceuticals Reports Year-End and Fourth Quarter 2010 Financial Results and Product Development Update - Globe Newswire |
|
More News for ACUR >> |
|
|
